Short-term follow-up US leads to higher false-positive results without detection of structural recurrences in PTMC

Jung Hyun Yoon, Hye Sun Lee, Eunkyung Kim, Ji Hyun Youk, Hyun Gi Kim, Hee Jung Moon, jinyoung kwak

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To investigate the value of the annual follow-up neck ultrasonography (US) for postoperative surveillance in patients with papillary thyroid microcarcinoma (PTMC). This retrospective study has been approved by our institutional review board (IRB) with waiver for informed consent. A total of 375 patients diagnosed as PTMCs, who underwent total thyroidectomy with radioiodine remnant ablation were included, to identify the recurrence rate and the false-positive rate of annual ultrasound. The number, interval, and the results of follow-up US or fine needle aspiration were obtained from electronic medical records. Four (1.1%, 4/375) recurrences were found 3 years after the initial treatment, and only 1 patient (0.3%, 1/375) had a metastatic lymph node larger than 8mm in the shortest diameter on US found 7.6 years after initial treatment with biochemical abnormalities. Cumulative risk of having at least 1 false-positive exam was 8.3% by the 8th US, and 8.1% by the 8-9 year follow-up. Cox multivariate regression showed shorter interval of follow-up US and presence of lymph node metastasis at initial surgery are independent predictors affecting the cumulative falsepositive results (hazard ratio [HR], 0.60; 95% confidence interval [CI]: 0.49-0.73; P<0.001 and HR, 2.19; 95% CI: 1.01-4.75; P=0.048, respectively). Short-term follow-up US can result in higher cumulative falsepositive results without detection of meaningful recurrences in patients with PTMCs who do not have biochemical abnormalities.

Original languageEnglish
Article numbere2435
JournalMedicine (United States)
Volume95
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Ultrasonography
Recurrence
Lymph Nodes
Confidence Intervals
Electronic Health Records
Research Ethics Committees
Thyroidectomy
Fine Needle Biopsy
Informed Consent
Papillary Thyroid Microcarcinoma
Neck
Retrospective Studies
Neoplasm Metastasis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{e13050fbae114847bb855771a80325bd,
title = "Short-term follow-up US leads to higher false-positive results without detection of structural recurrences in PTMC",
abstract = "To investigate the value of the annual follow-up neck ultrasonography (US) for postoperative surveillance in patients with papillary thyroid microcarcinoma (PTMC). This retrospective study has been approved by our institutional review board (IRB) with waiver for informed consent. A total of 375 patients diagnosed as PTMCs, who underwent total thyroidectomy with radioiodine remnant ablation were included, to identify the recurrence rate and the false-positive rate of annual ultrasound. The number, interval, and the results of follow-up US or fine needle aspiration were obtained from electronic medical records. Four (1.1{\%}, 4/375) recurrences were found 3 years after the initial treatment, and only 1 patient (0.3{\%}, 1/375) had a metastatic lymph node larger than 8mm in the shortest diameter on US found 7.6 years after initial treatment with biochemical abnormalities. Cumulative risk of having at least 1 false-positive exam was 8.3{\%} by the 8th US, and 8.1{\%} by the 8-9 year follow-up. Cox multivariate regression showed shorter interval of follow-up US and presence of lymph node metastasis at initial surgery are independent predictors affecting the cumulative falsepositive results (hazard ratio [HR], 0.60; 95{\%} confidence interval [CI]: 0.49-0.73; P<0.001 and HR, 2.19; 95{\%} CI: 1.01-4.75; P=0.048, respectively). Short-term follow-up US can result in higher cumulative falsepositive results without detection of meaningful recurrences in patients with PTMCs who do not have biochemical abnormalities.",
author = "Yoon, {Jung Hyun} and Lee, {Hye Sun} and Eunkyung Kim and Youk, {Ji Hyun} and Kim, {Hyun Gi} and Moon, {Hee Jung} and jinyoung kwak",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MD.0000000000002435",
language = "English",
volume = "95",
journal = "Medicine (United States)",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Short-term follow-up US leads to higher false-positive results without detection of structural recurrences in PTMC. / Yoon, Jung Hyun; Lee, Hye Sun; Kim, Eunkyung; Youk, Ji Hyun; Kim, Hyun Gi; Moon, Hee Jung; kwak, jinyoung.

In: Medicine (United States), Vol. 95, No. 1, e2435, 01.01.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Short-term follow-up US leads to higher false-positive results without detection of structural recurrences in PTMC

AU - Yoon, Jung Hyun

AU - Lee, Hye Sun

AU - Kim, Eunkyung

AU - Youk, Ji Hyun

AU - Kim, Hyun Gi

AU - Moon, Hee Jung

AU - kwak, jinyoung

PY - 2016/1/1

Y1 - 2016/1/1

N2 - To investigate the value of the annual follow-up neck ultrasonography (US) for postoperative surveillance in patients with papillary thyroid microcarcinoma (PTMC). This retrospective study has been approved by our institutional review board (IRB) with waiver for informed consent. A total of 375 patients diagnosed as PTMCs, who underwent total thyroidectomy with radioiodine remnant ablation were included, to identify the recurrence rate and the false-positive rate of annual ultrasound. The number, interval, and the results of follow-up US or fine needle aspiration were obtained from electronic medical records. Four (1.1%, 4/375) recurrences were found 3 years after the initial treatment, and only 1 patient (0.3%, 1/375) had a metastatic lymph node larger than 8mm in the shortest diameter on US found 7.6 years after initial treatment with biochemical abnormalities. Cumulative risk of having at least 1 false-positive exam was 8.3% by the 8th US, and 8.1% by the 8-9 year follow-up. Cox multivariate regression showed shorter interval of follow-up US and presence of lymph node metastasis at initial surgery are independent predictors affecting the cumulative falsepositive results (hazard ratio [HR], 0.60; 95% confidence interval [CI]: 0.49-0.73; P<0.001 and HR, 2.19; 95% CI: 1.01-4.75; P=0.048, respectively). Short-term follow-up US can result in higher cumulative falsepositive results without detection of meaningful recurrences in patients with PTMCs who do not have biochemical abnormalities.

AB - To investigate the value of the annual follow-up neck ultrasonography (US) for postoperative surveillance in patients with papillary thyroid microcarcinoma (PTMC). This retrospective study has been approved by our institutional review board (IRB) with waiver for informed consent. A total of 375 patients diagnosed as PTMCs, who underwent total thyroidectomy with radioiodine remnant ablation were included, to identify the recurrence rate and the false-positive rate of annual ultrasound. The number, interval, and the results of follow-up US or fine needle aspiration were obtained from electronic medical records. Four (1.1%, 4/375) recurrences were found 3 years after the initial treatment, and only 1 patient (0.3%, 1/375) had a metastatic lymph node larger than 8mm in the shortest diameter on US found 7.6 years after initial treatment with biochemical abnormalities. Cumulative risk of having at least 1 false-positive exam was 8.3% by the 8th US, and 8.1% by the 8-9 year follow-up. Cox multivariate regression showed shorter interval of follow-up US and presence of lymph node metastasis at initial surgery are independent predictors affecting the cumulative falsepositive results (hazard ratio [HR], 0.60; 95% confidence interval [CI]: 0.49-0.73; P<0.001 and HR, 2.19; 95% CI: 1.01-4.75; P=0.048, respectively). Short-term follow-up US can result in higher cumulative falsepositive results without detection of meaningful recurrences in patients with PTMCs who do not have biochemical abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=84955263029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955263029&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000002435

DO - 10.1097/MD.0000000000002435

M3 - Article

VL - 95

JO - Medicine (United States)

JF - Medicine (United States)

SN - 0025-7974

IS - 1

M1 - e2435

ER -